Cytokine and Epigenetic Regulation of Programmed Death-Ligand 1 in Stem Cell Differentiation and Cancer Cell Plasticity
Open Access
- 28 June 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 39 (10) , 1298-1309
Abstract
Programmed death-ligand 1 (PD-L1), an immune checkpoint ligand, is recognized as a potential target for cancer immunotherapy as well as for the induction of transplantation tolerance. However, how the crosstalk between stem cell programming and cytokine signaling regulates PD-L1 expression during stem cell differentiation and cancer cell plasticity remains unclear. Herein, we reported that PD-L1 expression was regulated by SOX2 during embryonic stem cell (ESC) differentiation and lung cancer cell plasticity. PD-L1 was induced during ESC differentiation to fibroblasts and was downregulated during SOX2-mediated reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs). Furthermore, SOX2 activation affected cancer cell plasticity and inhibited PD-L1 expression in lung cancer cells. We discovered that the H3K27ac signal at the PD-L1 locus was enhanced during ESC differentiation to fibroblasts as well as during cancer plasticity of SOX2-positive lung cancer cells to SOX2-negative counterparts. Romidepsin, an epigenetic modifier, induced PD-L1 expression in lung cancer cells, whereas TGF-β stimulation downregulated SOX2 but upregulated PD-L1 expression in lung cancer cells. Furthermore, in addition to PD-L1, the expressions of EGFR and its ligand HBEGF were downregulated by activation of endogenous SOX2 expression during lung cancer cell plasticity and iPSC reprogramming, and the activation of EGFR signaling by HBEGF upregulated PD-L1 expression in lung cancer cells. Together, our results reveal the crosstalk between SOX2 programming and cytokine stimulation influences PD-L1 expression, and these findings may provide insights into PD-L1-mediated therapeutics.Keywords
Funding Information
- Ministry of Science and Technology (109-2320-B-007-003-MY3)
- National Tsing Hua University (107Q2530E1)
- Veterans General Hospitals and University System of Taiwan Joint Research Program (VGHUST109-V1-4-2)
- National Tsing Hua University (107Q2530E1)
This publication has 49 references indexed in Scilit:
- Small RNA‐mediated regulation of iPS cell generationThe EMBO Journal, 2011
- Sox2 Uses Multiple Domains to Associate with Proteins Present in Sox2-Protein ComplexesPLOS ONE, 2010
- Evidence That SOX2 Overexpression Is Oncogenic in the LungPLOS ONE, 2010
- A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing NanogCell Stem Cell, 2009
- Tgfβ Signal Inhibition Cooperates in the Induction of iPSCs and Replaces Sox2 and cMycCurrent Biology, 2009
- Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotencyNature Methods, 2009
- TGF-β: A Master of All T Cell TradesCell, 2008
- Regulation of Self-Renewal and Pluripotency by Sox2 in Human Embryonic Stem CellsStem Cells, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Defective Expression of Transforming Growth Factor β Receptor Type II Is Associated with CpG Methylated Promoter in Primary Non-Small Cell Lung CancerClinical Cancer Research, 2004